Skip to content

Evaluation of the Relationship Between Missed Appointments and Adherence to Medical Indications

Evaluation of the Relationship Between Non-attendance to Appointments and Adherence to Medical Indications, in Adult Patients, With Type 2 Diabetes Mellitus, During the COVID-19 Pandemic: Cross-sectional Studio.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06501456
Enrollment
46
Registered
2024-07-15
Start date
2020-07-01
Completion date
2020-08-01
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, No-Show Patients, Therapeutic Adherence and Compliance, Type 2 Diabetes Mellitus

Keywords

No Show Patients, Patient Compliance, Type 2 diabetes mellitus, COVID-19

Brief summary

We will conduct a cross-sectional study involving adults with type 2 diabetes mellitus. Our primary objective is to evaluate the association between nonattendance and participants' adherence to both pharmacological and non-pharmacological medical recommendations, as well as COVID-19 prevention measures. Additionally, we will assess the adherence rates to these medical recommendations, COVID-19 prevention protocols, and the recommended health care practices and controls for patients with type 2 diabetes mellitus.

Detailed description

Non-attendance at outpatient visits and lack of adherence to medical recommendations are prevalent issues that negatively impact the health care system. While tools exist to assess pharmacological adherence, evaluating adherence to non-pharmacological recommendations remains challenging. Some studies suggest using nonattendance as an objective and easily measurable marker of adherence. The aim of this study is to evaluate the association between nonattendance and adherence to medical recommendations in adults with type 2 diabetes mellitus. We will conduct a cross-sectional study involving adults with type 2 diabetes mellitus. We will evaluate the association between participants' nonattendance and their adherence to both pharmacological and non-pharmacological medical recommendations, as well as COVID-19 prevention measures. Additionally, we will assess the adherence rates to these recommendations, COVID-19 prevention measures, and the recommended health care practices and controls for patients with type 2 diabetes mellitus.

Interventions

None listed

Sponsors

Hospital Italiano de Buenos Aires
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (over 18 years old), affiliated with the medical insurance of the Hospital Italiano de Buenos Aires for at least two years. * Patients with a diagnosis of type 2 diabetes mellitus at least 2 years before the date of entry to the study Will be included.

Exclusion criteria

* Refusal to participate or to the informed consent process. * Difficulties with language or comprehension (includes pathologies that alter the understanding of the indications or compliance with them (dementia, encephalopathy, intellectual disability, psychiatric disorders). * Recent hospitalization (the month before the phone call). * Medical follow-up outside of Hospital Italiano de Buenos Aires. * Work as health personnel. * Communication failure (wrong phone number or no response to 3 calls on different days and times)

Design outcomes

Primary

MeasureTime frameDescription
Association between non-attendance to scheduled outpatient shifts and adherence to doctor's instructions in adult patients2020 - 2021Measured the association between absenteeism from outpatient visits and adherence to medical indications in adults with type 2 diabetes mellitus.

Secondary

MeasureTime frameDescription
Adherence of patients with type 2 diabetes mellitus to medical indications during the pandemicJuly 2020Report the adherence of patients with type 2 diabetes mellitus to medical indications during the pandemic

Countries

Argentina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026